Immunome, Inc. (IMNM)
NASDAQ: IMNM · USD
$23.1
-0.11 (-0.5%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first IMNM analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 2.6B | |
|---|---|---|
| Revenue (ttm) | 4M | |
| Net income (ttm) | -224.6M | |
| EPS (ttm) | -$2.34 | |
| Shares out | 113.3M | |
| Volume | 794,063 | |
| Beta | 2.07 | |
| Price target | $35.8 | +54.8% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Revenue (ttm)
- 4M
- Net income (ttm)
- -224.6M
- EPS (ttm)
- -$2.34
- Market cap
- 2.6B
Fair-value bridge
- Current price
- $23.1
Analyst consensus
Recommendation
Strong Buy
Price target
$35.8
+54.8%
In the news
Latest news · IMNM
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 2.6B
- P/S
- 651.9x
- P/B
- 4.4x
Profitability
- Operating margin
- -5698.8%
- ROE
- -50.1%
- ROA
- -29.7%
- ROIC
- -31.6%
Balance sheet
- Debt / equity
- 0.01
- Current ratio
- 21.68
- Quick ratio
- 21.26
Trading
- Beta
- 2.07
- Volume
- 794,063
- Dividend yield
- 0.0%